8 enrolling by invitation. 8 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Enrolling by invitation 8 |
| Phase 1 | 2 | Enrolling by invitation 2 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab Foralumab Nasal, Placebo - ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis | Phase 2 | Enrolling by invitation | Tiziana Life Sciences LTD | 44 | 2026-09-23 | 2026-10-28 |
| Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial Colchicine 0.5 MG oral tablet twice daily, Placebo Oral Tablet - Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) | Phase 2 / Phase 3 | Enrolling by invitation | National Taiwan University Hospital | 400 | 2026-07-06 | 2026-07-10 |
| Racecadotril for Organ Injury in Sepsis Patients Racecadotril, Water (Placebo) - Sepsis | Phase 1 / Phase 2 | Enrolling by invitation | Zhujiang Hospital | 44 | 2026-05-06 | 2026-05-28 |
| The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions Ciplukan, Bethametasone valerate 0,1% cream - Psoriasis Vulgaris, Inflammation | Phase 1 / Phase 2 | Enrolling by invitation | Universitas Padjadjaran | 40 | 2025-02-13 | 2025-04-01 |
| Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 IV normal saline, IV immunoglobulin - Systemic Inflammation, Neuroinflammation | Phase 2 | Enrolling by invitation | National Institute of Neurological Disorders and Stroke (NINDS) | 45 | 2023-07-10 | 2026-10-26 |
| Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias C-11 ER-176, Blood Test - Lewy Body Dementia (LBD), Alzheimer Dementia (AD) | Phase 2 | Enrolling by invitation | Val Lowe | 125 | 2021-03-30 | 2026-05-22 |
| Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults Fisetin, Placebo oral capsule - Frail Elderly Syndrome | Phase 2 | Enrolling by invitation | Mayo Clinic | 40 | 2018-11-15 | 2026-05-22 |
| Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Fisetin, Placebo oral capsule - Frail Elderly Syndrome | Phase 2 | Enrolling by invitation | Mayo Clinic | 40 | 2018-02-06 | 2026-05-11 |
Neuroinflammatory Diseases (3) · Frailty (2) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · COVID-19 (1) · Lewy Body Disease (1) · Post-Acute COVID-19 Syndrome (1) · Sepsis (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Nervous System Diseases (3) · Central Nervous System Diseases (2) · Infections (2) · Neurodegenerative Diseases (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Dementia (1) · Disease Attributes (1) · Lung Diseases (1)
fisetin (2) · Colchicine (1) · Hematologic Tests (1) · Immunoglobulins, Intravenous (1) · Saline Solution (1) · Water (1) · racecadotril (1)
Mayo Clinic (2) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Taiwan University Hospital (1) · Tiziana Life Sciences LTD (1) · Universitas Padjadjaran (1) · Val Lowe (1) · Zhujiang Hospital (1)
United States (5) · China (1) · Indonesia (1) · Taiwan (1)
Sundeep Khosla, MD (2) · Avindra Nath, M.D. (1) · Dr. Harry Galuh Nugraha, dr., Sp.Rad(K) (1) · Miranti Pangastuti, dr., Sp.D.V.E., Subsp.D.A.I (1) · Prof. Dr. Oki Suwarsa, dr., Sp.D.V.E., Subsp.D.A.I., M.Kes (1) · Robert J Pignolo, MD, PhD (1) · Robert Pignolo, MD, PhD (1) · Val Lowe, MD (1) · Zhanguo Liu, M.D.PhD (1)